Barclays’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7M | Sell |
94,058
-1,661
| -2% | -$542K | 0.01% | 665 |
|
|
2025
Q1 | $25.8M | Sell |
95,719
-8,128
| -8% | -$2.19M | 0.01% | 661 |
|
|
2024
Q4 | $24.4M | Sell |
103,847
-1,338
| -1% | -$315K | 0.01% | 708 |
|
|
2024
Q3 | $28.9M | Sell |
105,185
-26,080
| -20% | -$7.17M | 0.01% | 643 |
|
|
2024
Q2 | $31.9M | Sell |
131,265
-62,707
| -32% | -$15.2M | 0.01% | 592 |
|
|
2024
Q1 | $29M | Buy |
193,972
+51,972
| +37% | +$7.77M | 0.01% | 648 |
|
|
2023
Q4 | $27.2M | Sell |
142,000
-20,195
| -12% | -$3.87M | 0.01% | 661 |
|
|
2023
Q3 | $28.7M | Sell |
162,195
-47,950
| -23% | -$8.49M | 0.02% | 600 |
|
|
2023
Q2 | $39.9M | Buy |
210,145
+68,550
| +48% | +$13M | 0.03% | 505 |
|
|
2023
Q1 | $28.4M | Sell |
141,595
-20,539
| -13% | -$4.11M | 0.01% | 498 |
|
|
2022
Q4 | $38.5M | Buy |
162,134
+20,780
| +15% | +$4.94M | 0.02% | 443 |
|
|
2022
Q3 | $28.3M | Buy |
141,354
+15,233
| +12% | +$3.05M | 0.03% | 477 |
|
|
2022
Q2 | $18.4M | Buy |
126,121
+46,523
| +58% | +$6.79M | 0.01% | 621 |
|
|
2022
Q1 | $13M | Sell |
79,598
-2,367
| -3% | -$386K | 0.01% | 798 |
|
|
2021
Q4 | $13.9M | Sell |
81,965
-15,510
| -16% | -$2.63M | 0.01% | 774 |
|
|
2021
Q3 | $18.4M | Sell |
97,475
-5,551
| -5% | -$1.05M | 0.01% | 710 |
|
|
2021
Q2 | $17.5M | Buy |
103,026
+25,161
| +32% | +$4.27M | 0.01% | 733 |
|
|
2021
Q1 | $11M | Buy |
77,865
+14,890
| +24% | +$2.1M | 0.01% | 805 |
|
|
2020
Q4 | $8.19M | Sell |
62,975
-31,520
| -33% | -$4.1M | ﹤0.01% | 838 |
|
|
2020
Q3 | $13.8M | Sell |
94,495
-21,693
| -19% | -$3.16M | 0.01% | 620 |
|
|
2020
Q2 | $17.2M | Buy |
116,188
+13,473
| +13% | +$2M | 0.01% | 488 |
|
|
2020
Q1 | $11.2M | Buy |
102,715
+41,557
| +68% | +$4.52M | 0.01% | 574 |
|
|
2019
Q4 | $7.04M | Sell |
61,158
-39,729
| -39% | -$4.58M | ﹤0.01% | 1016 |
|
|
2019
Q3 | $8.11M | Buy |
100,887
+34,994
| +53% | +$2.81M | 0.01% | 869 |
|
|
2019
Q2 | $4.78M | Buy |
65,893
+15,770
| +31% | +$1.14M | ﹤0.01% | 1119 |
|
|
2019
Q1 | $4.68M | Sell |
50,123
-23,443
| -32% | -$2.19M | ﹤0.01% | 1008 |
|
|
2018
Q4 | $5.36M | Buy |
73,566
+3,892
| +6% | +$284K | ﹤0.01% | 913 |
|
|
2018
Q3 | $6.1M | Buy |
69,674
+19,562
| +39% | +$1.71M | ﹤0.01% | 956 |
|
|
2018
Q2 | $4.94M | Buy |
50,112
+33,094
| +194% | +$3.26M | ﹤0.01% | 984 |
|
|
2018
Q1 | $2.03M | Sell |
17,018
-68,526
| -80% | -$8.16M | ﹤0.01% | 1358 |
|
|
2017
Q4 | $10.9M | Buy |
85,544
+74,097
| +647% | +$9.41M | 0.01% | 652 |
|
|
2017
Q3 | $1.34M | Sell |
11,447
-42,875
| -79% | -$5.03M | ﹤0.01% | 1427 |
|
|
2017
Q2 | $4.33M | Buy |
54,322
+3,689
| +7% | +$294K | ﹤0.01% | 854 |
|
|
2017
Q1 | $2.6M | Sell |
50,633
-539
| -1% | -$27.6K | ﹤0.01% | 1057 |
|
|
2016
Q4 | $1.92M | Buy |
51,172
+33,285
| +186% | +$1.25M | ﹤0.01% | 1173 |
|
|
2016
Q3 | $1.21M | Buy |
17,887
+8,385
| +88% | +$569K | ﹤0.01% | 1318 |
|
|
2016
Q2 | $527K | Sell |
9,502
-18,734
| -66% | -$1.04M | ﹤0.01% | 1735 |
|
|
2016
Q1 | $1.75M | Buy |
28,236
+15,269
| +118% | +$947K | ﹤0.01% | 1146 |
|
|
2015
Q4 | $1.22M | Sell |
12,967
-26,166
| -67% | -$2.46M | ﹤0.01% | 1263 |
|
|
2015
Q3 | $3.13M | Buy |
39,133
+26,649
| +213% | +$2.13M | ﹤0.01% | 879 |
|
|
2015
Q2 | $1.49M | Buy |
12,484
+3,617
| +41% | +$431K | ﹤0.01% | 1293 |
|
|
2015
Q1 | $922K | Buy |
8,867
+8,339
| +1,579% | +$867K | ﹤0.01% | 1646 |
|
|
2014
Q4 | $51K | Sell |
528
-32,831
| -98% | -$3.17M | ﹤0.01% | 3001 |
|
|
2014
Q3 | $2.6M | Sell |
33,359
-28,462
| -46% | -$2.22M | ﹤0.01% | 1274 |
|
|
2014
Q2 | $3.89M | Buy |
61,821
+51,955
| +527% | +$3.27M | ﹤0.01% | 1066 |
|
|
2014
Q1 | $661K | Sell |
9,866
-18,099
| -65% | -$1.21M | ﹤0.01% | 1864 |
|
|
2013
Q4 | $1.79M | Buy |
27,965
+19,987
| +251% | +$1.28M | ﹤0.01% | 1456 |
|
|
2013
Q3 | $510K | Sell |
7,978
-35,234
| -82% | -$2.25M | ﹤0.01% | 2096 |
|
|
2013
Q2 | $1.34M | Buy |
+43,212
| New | +$1.34M | ﹤0.01% | 1551 |
|